Literature DB >> 23319847

Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.

Luigi Brunetti, Julie Kalabalik.   

Abstract

Successful management of hyperglycemia may involve glucose and non-glucose therapies, non-drug approaches, and non-insulin agents. Treatment should be tailored to each patient, with an emphasis on safety.

Entities:  

Year:  2012        PMID： 23319847      PMCID： PMC3541864     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  78 in total

1.  2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; W Klein-Schwartz; S White; D J Cobaugh; J Youniss; J C Omslaer; A Drab; B E Benson
Journal:  Am J Emerg Med       Date:  2001-09       Impact factor: 2.469

Review 2.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

3.  Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.

Authors:  Dennis Kim; Leigh MacConell; Dongliang Zhuang; Prajakti A Kothare; Michael Trautmann; Mark Fineman; Kristin Taylor
Journal:  Diabetes Care       Date:  2007-03-12       Impact factor: 19.112

4.  The nuclear receptor LXR is a glucose sensor.

Authors:  Nico Mitro; Puiying A Mak; Leo Vargas; Cristina Godio; Eric Hampton; Valentina Molteni; Andreas Kreusch; Enrique Saez
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

Review 5.  Improving treatment success rates for type 2 diabetes: recommendations for a changing environment.

Authors:  Curtis Triplitt
Journal:  Am J Manag Care       Date:  2010-08       Impact factor: 2.229

Review 6.  Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Katherine R Gerrald; E Van Scoyoc; R C Wines; T Runge; D E Jonas
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

7.  An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes.

Authors:  Jeanette M Daly; Arthur J Hartz; Yinghui Xu; Barcey T Levy; Paul A James; Mary L Merchant; Robert E Garrett
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

Review 8.  Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.

Authors:  Ralph A Defronzo
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

9.  Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.

Authors:  Michael A Via; Himani Chandra; Takako Araki; Matthew V Potenza; Maria Skamagas
Journal:  Diabetes Metab Syndr Obes       Date:  2010-03-26       Impact factor: 3.168

10.  Projecting the future diabetes population size and related costs for the U.S.

Authors:  Elbert S Huang; Anirban Basu; Michael O'Grady; James C Capretta
Journal:  Diabetes Care       Date:  2009-12       Impact factor: 19.112
View more
  4 in total

1.  Level of A1C control and its predictors among Lebanese type 2 diabetic patients.

Authors:  Hanan Noureddine; Nancy Nakhoul; Amal Galal; Lama Soubra; Mounzer Saleh
Journal:  Ther Adv Endocrinol Metab       Date:  2014-06       Impact factor: 3.565

2.  Solid Lipid Nanoparticles of Myricitrin Have Antioxidant and Antidiabetic Effects on Streptozotocin-Nicotinamide-Induced Diabetic Model and Myotube Cell of Male Mouse.

Authors:  Akram Ahangarpour; Ali Akbar Oroojan; Layasadat Khorsandi; Maryam Kouchak; Mohammad Badavi
Journal:  Oxid Med Cell Longev       Date:  2018-07-17       Impact factor: 6.543

Review 3.  Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.

Authors:  Jesús Chávez-Reyes; Carlos E Escárcega-González; Erika Chavira-Suárez; Angel León-Buitimea; Priscila Vázquez-León; José R Morones-Ramírez; Carlos M Villalón; Andrés Quintanar-Stephano; Bruno A Marichal-Cancino
Journal:  Front Public Health       Date:  2021-02-16

4.  Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.

Authors:  Chintan Shah; Young-Rock Hong; Rohit Bishnoi; Azka Ali; William Paul Skelton; Long H Dang; Jinhai Huo; Nam H Dang
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.